Skip to main content
Clinical Trials/NCT00682162
NCT00682162CompletedPhase 3

Impact of Acupuncture on Vasomotor Rhinitis: a Randomised Placebo Controlled Pilot Study

Ludwig-Maximilians - University of Munich2 sites in 1 country24 target enrollmentStarted: January 1998Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
24
Locations
2
Primary Endpoint
The main outcome measure was the alteration of the nasal sickness score (NSS; scoremax 27).

Study Overview

Brief Summary

Chronic rhinitis without an allergic or infectious aetiology (vasomotor rhinitis) is a common disease for which there are only poor therapeutic treatment options. The current placebo controlled partially double blinded pilot study evaluated the effects of acupuncture on the symptoms of vasomotor rhinitis.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • term of sickness > 3 month
  • negative allergic testing

Exclusion Criteria

  • term of sickness < 3 month
  • previous nasal surgeries
  • polyposis nasi
  • contraindications regarding acupuncture (such as: risk of bleeding, pregnancy)
  • psychologic disorders
  • drug addiction
  • autoimmune disease
  • other severe disease

Outcomes

Primary Outcomes

The main outcome measure was the alteration of the nasal sickness score (NSS; scoremax 27).

Time Frame: 5 weeks

Secondary Outcomes

  • Secondary outcome measures were the evaluation of a subjective symptoms score by patients' diaries and of their quality of life (SF-12 health survey).(5 weeks)

Investigators

Study Sites (2)

Loading locations...

Similar Trials